We only have this paper's title and publication details.
Read it at the sourceCaptured external expert commentary on this paper, strongest first. Original sources are linked where available.
“a comprehensive review of the findings from clinical trials that provide the most up-to-date and expert recommendations for the management of patients with these potentially life-threatening conditions.”
“The addition of the S-ICD System to these clinical guidelines reinforces the value this device can bring to a broad ICD-indicated patient population, through avoidance of transvenous lead-specific complications. The clinical significance of the updated guidelines provides a call to action for physicians to include the S-ICD System in shared decision making with their ICD-indicated patients.”
“Sudden cardiac arrest and sudden cardiac death are major public health problems, accounting for approximately half of all cardiovascular deaths, with at least 25 percent being first manifestation of cardiac disease. The risks of ventricular arrhythmias and sudden cardiac death vary in specific populations with different underlying cardiac conditions, and with specific family history and genetic variants, and this variation has important implications for studying and applying therapies.”
No takes yet. Share an insight, caveat, or question.
Al‐Khatib et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: